🇯🇵 Japan Country × Condition
hypercholesterolemia Clinical Trials in Japan
Active clinical trials for hypercholesterolemia with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT05325034
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Enrollment
2,000 pts
Country
🇯🇵 Japan
Stephen Nicholls
View Trial → NCT07634484 Phase 4
Recruiting
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
Enrollment
120 pts
Country
🇯🇵 Japan
Kowa Company, Ltd.
View Trial → Frequently Asked Questions
How many hypercholesterolemia clinical trials are active in Japan?
There are currently 2 active clinical trials for hypercholesterolemia with sites in Japan, of which 2 are actively recruiting patients.
How can I join a hypercholesterolemia clinical trial in Japan?
To join a hypercholesterolemia clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hypercholesterolemia trials in Japan?
Active hypercholesterolemia trials in Japan span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology